Testing personalized blood pressure targets in severe heart failure

This trial is testing whether personalizing blood pressure targets during cardiogenic shock (a life-threatening form of severe heart failure) can improve survival and protect organs. Half of participants will receive treatment aimed at a standard blood pressure target, while the other half will receive treatment with a blood pressure target customized to their individual condition. The goal is to see if a personalized approach works better than the current standard approach.

Cardiogenic shock is extremely serious, with very high death rates even with current treatments. Doctors know that blood pressure matters during this condition, but they're not sure what the best target should be. This trial exists to find out whether tailoring the blood pressure goal to each patient's unique situation—rather than using a one-size-fits-all approach—can save more lives and prevent organ damage.